Interestingly, however, the concomitant loss of ASCL1 in vivo in one study did not stop NE small cell tumour formation, suggesting a compensatory mechanism by other NE drivers [88]; however, a similar in vivo study showed moderate tumour control by ASCL1 knockout [89]. Here, ASCL1 is linked to neoplasm.